Functional IOL Implantation in Patients With Epiretinal Membrane
NCT06719739
Cataract, Epiretinal Membrane
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT Number: NCT03404323
The purpose of the study is to evaluate retinal thickness change and the occurrence of central structural retinal changes after uneventful small-incision cataract surgery in eyes with asymptomatic early stages of epiretinal membrane.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Optical coherence tomography (OCT) is nowadays used in daily clinical practice and has become a helpful tool for detection of macular changes also in presence of opacification of the lens before cataract surgery. Using recent high-resolution OCT technology, early stages of epiretinal membranes can easily be detected and analysed. Since cataract surgery is one of the most frequently performed operations worldwide, this study was aimed to investigate the influence of uncomplicated cataract surgery on central retinal thickness and the incidence of structural and morphological macular changes after surgery in eyes with asymptomatic epiretinal membrane.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Change from Baseline central macular thickness at 3 months
Central 1-millimeter and 3-milimeter retinal thickness
St John of God Hospital, Vienna
Other
"Retinal Thickness Change Following Cataract Surgery in Eyes With Epiretinal Membrane"
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06719739
Cataract, Epiretinal Membrane
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT03713268
Cardiovascular Diseases, Cataract
Durham, North Carolina, United States
View Trial DetailsNCT05287269
Age Related Macular Degeneration, Cataract
Brighton, Sussex, United Kingdom
View Trial DetailsNCT01613716
Diabetes Mellitus, Diabetic Macular Edema
Cleveland, Ohio, United States
View Trial Details